These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 255131)

  • 1. A synthetic steroid (R2323) as a once-a-week oral contraceptive.
    David SS; Huggins GR; Garcia CR; Busacca C
    Fertil Steril; 1979 Mar; 31(3):278-81. PubMed ID: 255131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood glucose, insulin, cholesterol and triglyceride levels in women treated for six months with the weekly oral contraceptive R2323.
    Spellacy WN; Mahan CS; Buhi WC; Dumbaugh VA; Birk SA
    Contraception; 1978 Aug; 18(2):121-6. PubMed ID: 249676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestrinone in the treatment of myomas.
    Coutinho EM
    Acta Obstet Gynecol Scand Suppl; 1989; 150():39-46. PubMed ID: 2694740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of fibrocystic disease of the breast with gestrinone, a new trienic synthetic steroid with anti-estrogen, anti-progesterone properties.
    Coutinho EM; Azadian-Boulanger G
    Int J Gynaecol Obstet; 1984 Oct; 22(5):363-6. PubMed ID: 6151920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic experience with gestrinone.
    Coutinho EM
    Prog Clin Biol Res; 1990; 323():233-40. PubMed ID: 2406749
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term treatment of leiomyomas with gestrinone.
    Coutinho EM; Gonçalves MT
    Fertil Steril; 1989 Jun; 51(6):939-46. PubMed ID: 2656310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of histological and ultrastructural aspects of endometrium during treatment with gestrinone in women with amenorrhea or spotting.
    Fedele L; Marchini M; Baglioni A; Dell'Antonio G; Motta T
    Acta Obstet Gynecol Scand; 1990; 69(2):143-6. PubMed ID: 2386018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative clinical trial of the progestins R-2323 and levonorgestrel administered by subdermal implants.
    Alvarez F; Robertson DN; Montes de Oca V; Sivin I; Brache V; Faundes A
    Contraception; 1978 Aug; 18(2):151-62. PubMed ID: 249677
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of endometriosis with gestrinone (R-2323), a synthetic antiestrogen, antiprogesterone.
    Coutinho EM
    Am J Obstet Gynecol; 1982 Dec; 144(8):895-8. PubMed ID: 6216812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gestrinone in the treatment of menorrhagia.
    Turnbull AC; Rees MC
    Br J Obstet Gynaecol; 1990 Aug; 97(8):713-5. PubMed ID: 2205289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Laparoscopic diagnosis and evaluation of danazol or gestrinone therapy for endometriosis in sterility].
    Utsunomiya T; Sumioki H; Korenaga S; Matsuoka K; Korenga M; Kadota T
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):459-66. PubMed ID: 2967341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral gestrinone: a novel antiprogestin with no antitumor activity in endocrine-sensitive breast cancer.
    Cunningham D; Gazet JC; Ford HT; Coombes RC
    Cancer Treat Rep; 1987 Nov; 71(11):1091-2. PubMed ID: 3677115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of progesterone and R2323 on the development of dimethylbenzanthracene-induced mammary tumors.
    Kelly PA; Asselin J; Turcot-Lemay L; Labrie F; Raynaud JP
    Eur J Cancer (1965); 1979 Oct; 15(10):1243-51. PubMed ID: 230056
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of a once-a-week steroid contraceptive (R2323) on lipid and carbohydrate metabolism in women during three months of use.
    Spellacy WN; Buhi WC; Dumbaugh VA; Birk SA
    Fertil Steril; 1978 Sep; 30(3):289-92. PubMed ID: 710600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of endometriosis by vaginal administration of gestrinone.
    Coutinho EM; Azadian-Boulanger G
    Fertil Steril; 1988 Mar; 49(3):418-22. PubMed ID: 3342892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestrinone (R2323) binding to steroid receptors in human uterine endometrial cytosol.
    Tamaya T; Fujimoto J; Watanabe Y; Arahori K; Okada H
    Acta Obstet Gynecol Scand; 1986; 65(5):439-41. PubMed ID: 3490730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pelvic endometriosis with gestrinone--report on 9 cases.
    Tamaya T; Fujimoto J; Okada H
    Asia Oceania J Obstet Gynaecol; 1985 Sep; 11(3):403-9. PubMed ID: 3853455
    [No Abstract]   [Full Text] [Related]  

  • 18. Regression of uterine leiomyomas after treatment with gestrinone, an antiestrogen, antiprogesterone.
    Coutinho EM; Boulanger GA; Gonçalves MT
    Am J Obstet Gynecol; 1986 Oct; 155(4):761-7. PubMed ID: 3532799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized double-blind prospective trial of two doses of gestrinone in the treatment of endometriosis.
    Hornstein MD; Gleason RE; Barbieri RL
    Fertil Steril; 1990 Feb; 53(2):237-41. PubMed ID: 2404805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vaginal contraceptive pill.
    Coutinho E
    IPPF Med Bull; 1985 Feb; 19(1):2-3. PubMed ID: 12339969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.